Infant vegetable for Gastrointestinal Microbiota

University of Delaware, Newark, DE
Targeting 3 different conditionsInfant vegetable +3 moreN/ARecruitingLed by Jillian Trabulsi, PhD, RDResearch Sponsored by University of Delaware

Study Summary

This trial looks at how different complementary foods affect the good bacteria in the stomachs of babies who are only fed breastmilk.

Eligible Conditions
  • Gastrointestinal Microbiota
  • Healthy Subjects
  • Infants

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below
The baby only drinks breast milk and doesn't consume any other liquids or foods.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 0, 2, 4, 6, 8, 10, 12, 14
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 0, 2, 4, 6, 8, 10, 12, 14 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Body Weight Changes

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Infant vegetableExperimental Treatment1 Intervention
Pureed carrots
Group II: Infant meatExperimental Treatment1 Intervention
Pureed beef
Group III: Infant fruitExperimental Treatment1 Intervention
Pureed prunes
Group IV: Infant cerealActive Control1 Intervention
Oatmeal cereal

Find a site

Who is running the clinical trial?

University of DelawareLead Sponsor
142 Previous Clinical Trials
37,714 Total Patients Enrolled
American Society for Nutrition FoundationUNKNOWN
Jillian Trabulsi, PhD, RDPrincipal Investigator
University of Delaware

Media Library

Infant fruit Clinical Trial Eligibility Overview. Trial Name: NCT05492253 — N/A
Gastrointestinal Microbiota Research Study Groups: Infant meat, Infant cereal, Infant fruit, Infant vegetable
Gastrointestinal Microbiota Clinical Trial 2023: Infant fruit Highlights & Side Effects. Trial Name: NCT05492253 — N/A
Infant fruit 2023 Treatment Timeline for Medical Study. Trial Name: NCT05492253 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could I be a potential participant in this research study?

"This medical trial is seeking forty infants, ranging in age from 5 to 7 months old. To be eligible for the study and its associated treatments, participants must have been born vaginally within full term; they cannot be afflicted with any significant gastrointestinal illnesses (e.g., gastroesophageal reflux or Celiac disease); their diet must consist solely of liquid human milk; they need to possess enough physical strength and coordination such that they can sit up when supported; neither them nor their mother has had antibiotics recently; a parent/guardian over 18 years of age must provide consent for participation; and lastly, the infant should not"

Answered by AI

Are there any opportunities for individuals to participate in this research study?

"Evidence from demonstrates that this medical study is not currently open for enrollment. The trial was initially shared on September 1st, 2022 and the latest update occurred on August 4th, 2022; however, 858 other studies are still taking applications presently."

Answered by AI

Does the protocol of this clinical trial encompass enrollees aged 70 or younger?

"This clinical trial is only open to infants between 5 and 7 months of age. Additionally, 60 trials exist that cater to minors while 377 are designed for the elderly."

Answered by AI
~0 spots leftby Oct 2023